• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国成年人进行多种癌症检测测试的意愿。

Willingness of adults in the United States to have a multicancer detection test.

作者信息

Reiter Paul L, Katz Mira L

机构信息

College of Public Health, The Ohio State University, Columbus, OH, USA.

Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.

出版信息

Cancer Causes Control. 2025 May 31. doi: 10.1007/s10552-025-02014-2.

DOI:10.1007/s10552-025-02014-2
PMID:40448916
Abstract

PURPOSE

Multicancer detection (MCD) testing is an emerging approach with the potential to improve the cancer screening and early detection landscape. As the clinical utility of MCD testing is further determined, it is important to examine patients' willingness to have an MCD test.

METHODS

We conducted an online survey in September 2024 with a national sample of adults aged 45-80 from the United States (n = 1,043). Multivariable logistic regression identified correlates of participants' willingness to have an MCD test.

RESULTS

About three-fourths of participants (75.2%) indicated they were willing to have an MCD test if it was free or covered by health insurance, while only 16.9% were willing if the test cost $1,000 out of pocket. Participants were more willing to have a free MCD test if they had at least a college degree (odds ratio [OR] = 2.48, 95% confidence interval [CI] 1.12-5.48), had some form of health insurance (OR = 3.40, 95% CI 1.84-6.27), or had a routine medical check-up within the last year (OR = 1.62, 95% CI 1.01-2.59). The most commonly endorsed factors that would matter in participants' hypothetical MCD testing decisions were cost or health insurance coverage (60.7%), how well the test works (50.6%), and if a doctor recommended having a test (47.6%).

CONCLUSIONS

Most adults are willing to have an MCD test, if it is free or covered by health insurance. Findings can help guide programs about MCD testing for both patients and healthcare providers that are becoming increasingly necessary as MCD testing continues to be examined as a screening strategy.

摘要

目的

多癌检测(MCD)测试是一种新兴方法,有潜力改善癌症筛查和早期检测的局面。随着MCD测试的临床效用进一步确定,研究患者进行MCD测试的意愿很重要。

方法

我们于2024年9月对来自美国的45至80岁成年人全国样本(n = 1,043)进行了在线调查。多变量逻辑回归确定了参与者进行MCD测试意愿的相关因素。

结果

约四分之三的参与者(75.2%)表示,如果MCD测试免费或由医疗保险覆盖,他们愿意进行测试,而如果测试自付费用为1000美元,只有16.9%的人愿意。如果参与者至少拥有大学学位(优势比[OR] = 2.48,95%置信区间[CI] 1.12 - 5.48)、拥有某种形式的医疗保险(OR = 3.40,95% CI 1.84 - 6.27)或在过去一年进行过常规体检(OR = 1.62,95% CI 1.01 - 2.59),他们更愿意进行免费的MCD测试。在参与者假设的MCD测试决策中,最常被认可的重要因素是成本或医疗保险覆盖范围(60.7%)、测试的有效性(50.6%)以及医生是否推荐进行测试(47.6%)。

结论

如果MCD测试免费或由医疗保险覆盖,大多数成年人愿意进行该测试。随着MCD测试作为一种筛查策略不断受到审视,这些发现可为针对患者和医疗服务提供者的MCD测试项目提供指导,此类项目正变得越来越必要。

相似文献

1
Willingness of adults in the United States to have a multicancer detection test.美国成年人进行多种癌症检测测试的意愿。
Cancer Causes Control. 2025 May 31. doi: 10.1007/s10552-025-02014-2.
2
Colorectal cancer screening blood test: awareness and willingness among a national sample of adults post-Federal and Drug Administration approval.结直肠癌筛查血液检测:联邦药物管理局批准后全国成年人样本中的知晓度与意愿度
BMC Public Health. 2025 May 20;25(1):1853. doi: 10.1186/s12889-025-23065-9.
3
Multicancer Detection (MCD) Testing in Gastrointestinal Cancers: An Evolving Tool for Early Diagnosis.胃肠道癌症的多癌检测(MCD)测试:一种不断发展的早期诊断工具。
Curr Gastroenterol Rep. 2025 Mar 6;27(1):19. doi: 10.1007/s11894-025-00970-y.
4
Willingness of Adults in the United States to Receive HIV Testing in Dental Care Settings: Cross-Sectional Web-Based Study.美国成年人愿意在牙科保健环境中接受 HIV 检测:横断面网络研究。
JMIR Public Health Surveill. 2020 Jul 21;6(3):e17677. doi: 10.2196/17677.
5
Implementation of a Multicancer Detection (MCD) Test in a Tertiary Referral Center in Asymptomatic Patients: An 18-Month Prospective Cohort Study.在一家三级转诊中心对无症状患者实施多癌检测(MCD)测试:一项为期18个月的前瞻性队列研究。
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251329290. doi: 10.1177/21501319251329290. Epub 2025 Mar 25.
6
Willingness to pay for a National Health Insurance (NHI) in Saudi Arabia: a cross-sectional study.沙特阿拉伯国民健康保险(NHI)支付意愿的横断面研究。
BMC Public Health. 2022 May 12;22(1):951. doi: 10.1186/s12889-022-13353-z.
7
Cancer screening with multicancer detection tests: A translational science review.多癌种检测试验进行癌症筛查:转化科学述评。
CA Cancer J Clin. 2024 Jul-Aug;74(4):368-382. doi: 10.3322/caac.21833. Epub 2024 Mar 22.
8
Pilot Medical Certification飞行员医学认证
9
Findings From a National Survey of Older US Adults on Patient Willingness to Use Telehealth Services: Cross-Sectional Survey.一项针对美国老年成年人使用远程医疗服务意愿的全国性调查结果:横断面调查。
J Med Internet Res. 2024 May 23;26:e50205. doi: 10.2196/50205.
10
Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening.通过检测对照臂样本增加筛查试验的效能:多癌种检测筛查的应用。
J Natl Cancer Inst. 2024 Oct 1;116(10):1675-1682. doi: 10.1093/jnci/djae218.

本文引用的文献

1
Perceptions of Multicancer Detection Tests Among Primary Care Physicians and Laypersons: A Qualitative Study.多癌种早期检测筛查在初级保健医生和非医学专业人士中的认知:一项定性研究。
Cancer Med. 2024 Nov;13(21):e70281. doi: 10.1002/cam4.70281.
2
Public Perspectives on Multi-Cancer Early Detection: A Qualitative Study.公众对多癌种早期检测的看法:一项定性研究。
Cancer Control. 2024 Jan-Dec;31:10732748241291609. doi: 10.1177/10732748241291609.
3
Perceptions of multi-cancer early detection tests among communities facing barriers to health care.
面临医疗保健障碍的社区对多癌早期检测测试的认知。
Health Aff Sch. 2024 Aug 16;2(9):qxae102. doi: 10.1093/haschl/qxae102. eCollection 2024 Sep.
4
Intention to have blood-based multi-cancer early detection (MCED) screening: a cross-sectional population-based survey in England.有意愿进行基于血液的多癌早期检测(MCED)筛查:英格兰基于人群的横断面调查。
Br J Cancer. 2024 Oct;131(7):1202-1211. doi: 10.1038/s41416-024-02822-4. Epub 2024 Aug 27.
5
Perspectives on Clinical Adoption Barriers to Blood-Based Multi-Cancer Early Detection Tests across Stakeholders.各利益相关者对基于血液的多癌早期检测测试临床应用障碍的看法。
J Pers Med. 2024 Jun 1;14(6):593. doi: 10.3390/jpm14060593.
6
Attitudes to multi-cancer early detection (MCED) blood tests for population-based screening: A qualitative study in Great Britain.基于人群的筛查中多癌种早期检测(MCED)血液检测的态度:英国的一项定性研究。
Soc Sci Med. 2024 Apr;347:116762. doi: 10.1016/j.socscimed.2024.116762. Epub 2024 Mar 12.
7
Cancer screening with multicancer detection tests: A translational science review.多癌种检测试验进行癌症筛查:转化科学述评。
CA Cancer J Clin. 2024 Jul-Aug;74(4):368-382. doi: 10.3322/caac.21833. Epub 2024 Mar 22.
8
Primary Care Provider Receptivity to Multi-Cancer Early Detection Test Use in Cancer Screening.初级保健提供者对在癌症筛查中使用多癌早期检测测试的接受度。
J Pers Med. 2023 Nov 29;13(12):1673. doi: 10.3390/jpm13121673.
9
Primary Care Patient Interest in Multi-Cancer Early Detection for Cancer Screening.初级保健患者对用于癌症筛查的多癌早期检测的兴趣。
J Pers Med. 2023 Nov 16;13(11):1613. doi: 10.3390/jpm13111613.
10
American Cancer Society's report on the status of cancer disparities in the United States, 2023.美国癌症协会关于 2023 年美国癌症差异现状的报告。
CA Cancer J Clin. 2024 Mar-Apr;74(2):136-166. doi: 10.3322/caac.21812. Epub 2023 Nov 14.